KPTI Earnings Karyopharm Therapeutics Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–22 of 22
| Q2 2026 | 2026-06-30 | -3.51 | 2026-08-13 | 10-Q |
| Q1 2026 | 2026-03-31 | -1.24 | 2026-05-14 | 10-Q |
| FY 2025 | 2025-12-31 | -17.93 | 2026-02-13 | 10-K |
| Q3 2025 | 2025-09-30 | -10.93 | 2025-11-03 | 10-Q |
| Q2 2026 | 2025-06-30 | -7.11 | 2026-08-13 | 10-Q |
| Q1 2026 | 2025-03-31 | -2.77 | 2026-05-14 | 10-Q |
| FY 2025 | 2024-12-31 | -14.00 | 2026-02-13 | 10-K |
| Q3 2025 | 2024-09-30 | -10.40 | 2025-11-03 | 10-Q |
| Q2 2025 | 2024-06-30 | -7.16 | 2025-08-11 | 10-Q |
| Q1 2025 | 2024-03-31 | -4.85 | 2025-05-12 | 10-Q |
| FY 2025 | 2023-12-31 | -18.79 | 2026-02-13 | 10-K |
| Q3 2024 | 2023-09-30 | -0.89 | 2024-11-05 | 10-Q |
| Q2 2024 | 2023-06-30 | -0.59 | 2024-08-06 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.30 | 2024-05-08 | 10-Q |
| FY 2024 | 2022-12-31 | -2.02 | 2025-02-19 | 10-K |
| Q3 2023 | 2022-09-30 | -1.60 | 2023-11-02 | 10-Q |
| Q2 2023 | 2022-06-30 | -1.15 | 2023-08-02 | 10-Q |
| Q1 2023 | 2022-03-31 | -0.53 | 2023-05-04 | 10-Q |
| FY 2023 | 2021-12-31 | -1.65 | 2024-02-29 | 10-K |
| Q3 2022 | 2021-09-30 | -2.17 | 2022-11-03 | 10-Q |
| Q2 2022 | 2021-06-30 | -1.48 | 2022-08-04 | 10-Q |
| FY 2022 | 2020-12-31 | -2.72 | 2023-02-17 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.